Wiseheart Medval

Wiseheart Medval, founded in 2021, is an innovative biopharmaceutical company focusing on cell therapy for neurological diseases. The company's GMP-grade cell product manufacturing workshop, located in Beijing's Zhongguan Village Life Science Park, was officially put into operation in March 2022. Currently, research work related to the IND application for clinical trials with the National Medical Products Administration (NMPA) is being carried out at this site.